Walter M. Stadler to Tumor Burden
This is a "connection" page, showing publications Walter M. Stadler has written about Tumor Burden.
Connection Strength
0.180
-
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer. Cancer Med. 2013 Aug; 2(4):545-52.
Score: 0.105
-
Developing drugs that do not cause tumor regression. Clin Adv Hematol Oncol. 2003 Nov; 1(11):654-5.
Score: 0.054
-
Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med. 2010 Jun; 63(6):1601-9.
Score: 0.021